CNY-17062-47113
3 vaccinations
7 coded responses
40 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 232 / VA
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Pfizer-BioNTech
- 2021-03-10
-
2021-03-11
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: just a little sore at injection site, barely noticeable, like any other shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
-
2021-03-31
Dose 2 — Pfizer-BioNTech
-
2021-03-31
Survey response — day 0, dose 2MedDRA: Dysgeusia — Feeling: Good · HeadacheFree text: weird taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body achesAdult check-in
-
2021-04-06
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: GoodFree text: Weird taste in mouth stillMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — day 7, dose 2MedDRA: Taste disorder — Feeling: GoodFree text: Visiting dentist is 2 weeks on weird taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-06-30
- 2021-09-29
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2021-10-06
Survey response — day 0, dose 3MedDRA: Dysgeusia — Feeling: Good · Site: PainFree text: Weird taste in mouthMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Eczema, Injection site pain, Melanocytic naevus, Pre-existing disease, Weight increased — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteFree text: Since 1st shots in March-weight gain, eczema flare up, more moles (but wasn't sure to attribute to shots); just sore at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2022-01-05
- 2022-04-06
-
2022-10-07
Survey response — 12 months, dose 3MedDRA: Dry eye, Dysgeusia, Pain, Paranasal sinus hypersecretion, Toothache — Feeling: FairFree text: Recurring sinus drain impacting crown and dull pain on tooth where crown is coupled with very unpleasant taste- former symptom also; severe dry eye; no care sought yet but will when I have timeMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): just a little sore at injection site, barely noticeable, like any other shot
Release 6 — day 0, dose 2
Systemic reaction (other): weird taste in mouth
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Weird taste in mouth still
Release 7 — day 7, dose 2
Systemic reaction (other): Visiting dentist is 2 weeks on weird taste in mouth
Release 10 — day 0, dose 3
Systemic reaction (other): Weird taste in mouth
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Since 1st shots in March-weight gain, eczema flare up, more moles (but wasn't sure to attribute to shots); just sore at injection site
Release 12 — 12 months, dose 3
Symptoms: Recurring sinus drain impacting crown and dull pain on tooth where crown is coupled with very unpleasant taste- former symptom also; severe dry eye; no care sought yet but will when I have time
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dry eye | · | · | ✓ |
| SD | Dysgeusia | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Toothache | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Eczema | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Melanocytic naevus | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Taste disorder | ✓ | ✓ | ✓ |
| SRO | Weight increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release